NASDAQ$HSIC

Henry Schein Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Second quarter results were impacted by COVID-19, but sales improved across all business groups.

Henry Schein reported a decrease in net sales by 31.2% compared to Q2 2019, with a GAAP net loss of $11.4 million, or $0.08 per diluted share. The results reflect the impact of COVID-19, particularly in the Dental business, but sales improved as the quarter progressed due to the resumption of operations for dental and medical customers.

  • Q2 GAAP loss per diluted share from continuing operations was $0.08, compared to prior-year GAAP diluted EPS of $0.78.
  • Q2 non-GAAP diluted EPS from continuing operations was $0.00, compared to prior-year non-GAAP diluted EPS of $0.84.
  • Net sales for the quarter were $1.7 billion, a decrease of 31.2% compared to the second quarter of 2019.
  • The company is cautiously optimistic about the immediate future, focusing on cash management and monitoring global COVID-19 cases.

Headline financials

Total Revenue

$1.68B

Previous: $2.45B-31.2%
EPS (adj)

-$0.08

Previous: $0.84-109.0%
Free Cash Flow

-$10.8M

Previous: $115M-109.4%
Net Income

-$10.8M

Previous: $115M-109.4%
Operating Income

-$7.43M

Previous: $162M-104.6%
Gross Profit

$454M

Previous: $767M-40.8%
Cash & Equivalents

$296M

Previous: $84.9M+248.7%
Total Assets

$7.32B

Previous: $7.11B+2.9%
Stock-Based Comp

$5.16M

Previous: $12.7M-59.3%

Revenue & EPS history

Henry Schein · Revenue · Quarterly

$1.68B

Q2 2020-31.2%vs Q2 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Henry Schein · $1.56B total across 2 segments · Q2 2020

  • Global Dental
    $941M-41.2%
  • Global Medical
    $618M-11.4%

Forward guidance

Due to the continued uncertainty surrounding the COVID-19 pandemic and its impact to business operations, Henry Schein is not providing 2020 financial guidance at this time.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.4%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-0.6%

Avg return

30 days after

45%

31 / 69 earnings

Positive

+11.1%

Q4 2021

Best reaction

-8.5%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.3%-1.6%+4.6%
Q4 2025+5.8%+2.3%-8.5%
Q3 2025+10.9%+11.2%+13.5%
Q1 2025+2.0%+5.1%+7.8%
Q4 2024-2.3%-7.0%-10.6%
Q3 2024-3.2%-6.0%+0.2%
Q2 2024-5.4%-0.9%+0.4%
Q1 2024+6.2%+7.0%+0.1%
Q4 2023-5.1%-4.6%-6.3%
Q3 2023+7.5%+7.3%+15.5%
Q2 2023-2.8%-1.8%-5.1%
Q1 2023-4.5%-4.2%-6.1%
Q4 2022-6.2%-7.5%-12.8%
Q3 2022+1.8%+6.2%+21.2%
Q2 2022-4.9%-3.8%-7.3%
Q1 2022+7.4%+6.6%+5.6%
Q4 2021+11.1%+10.1%+14.5%
Q3 2021+3.0%+4.5%-6.7%
Q2 2021-4.8%-5.2%-2.3%
Q1 2021+6.6%+8.9%+5.3%
Q4 2020-8.5%-6.5%-5.3%
Q3 2020-5.0%-3.0%+4.6%
Q2 2020-5.3%-4.4%-6.9%
Q1 2020+0.4%+2.9%+20.6%
Q4 2019-8.4%-14.4%-38.9%
Q3 2019+4.4%+4.8%+5.2%
Q2 2019-3.2%-2.3%-4.2%
Q1 2019+8.6%+8.9%+8.6%
Q4 2018-5.0%-5.2%-5.2%
Q3 2018+3.1%+0.8%+3.3%
Q2 2018-0.5%-3.6%+0.5%
Q1 2018-6.1%-4.4%-6.7%
Q4 2017-1.2%-2.1%-5.2%
Q3 2017-8.5%-13.6%-13.0%
Q2 2017-7.7%-7.2%-4.9%
Q1 2017+0.6%+0.3%+5.2%
Q4 2016+2.7%+3.2%+2.0%
Q3 2016+4.6%+6.2%+1.7%
Q2 2016-7.1%-8.4%-8.6%
Q1 2016-2.5%
Q4 2015+7.0%
Q3 2015+1.1%
Q2 2015-1.9%
Q1 2015-0.4%
Q4 2014+0.9%
Q3 2014+5.4%
Q2 2014-1.8%
Q1 2014-1.7%
Q4 2013+0.1%
Q3 2013-2.6%
Q2 2013-0.3%
Q1 2013+2.1%
Q4 2012-2.2%
Q3 2012-0.6%
Q2 2012+1.8%
Q1 2012+2.4%
Q4 2011+3.4%
Q3 2011-6.4%
Q2 2011-2.3%
Q1 2010-2.0%
Q1 2011+0.5%
Q4 2010-3.9%
Q1 2009-3.9%
Q4 2008-3.9%
Q3 2009-4.1%
Q3 2010-4.1%
Q2 2010+2.1%
Q4 2009+2.1%
Q2 2009+2.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro